S Mallal

Summary

Affiliation: Murdoch University
Country: Australia

Publications

  1. ncbi Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
    S Mallal
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Perth, Australia
    Lancet 359:727-32. 2002
  2. ncbi Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
    D Nolan
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Australia
    AIDS 15:1275-80. 2001
  3. ncbi HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay
    E Hammond
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Wellington Street, Western Australia 6000, Australia
    Tissue Antigens 70:58-61. 2007
  4. ncbi Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV
    E Hammond
    Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia
    Clin Endocrinol (Oxf) 76:201-6. 2012
  5. ncbi Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis
    D Nolan
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia
    Antivir Ther 6:145-60. 2001
  6. ncbi The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
    P Price
    Department of Clinical Immunology, Royal Perth Hospital, Western Australia, Australia
    Immunol Rev 167:257-74. 1999
  7. ncbi Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care
    S Herrmann
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, WA, Australia
    Intern Med J 38:8-15. 2008
  8. ncbi Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?
    D Nolan
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Australia
    QJM 96:825-32. 2003

Collaborators

Detail Information

Publications8

  1. ncbi Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
    S Mallal
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Perth, Australia
    Lancet 359:727-32. 2002
    ..Genetic factors influencing the immune response to abacavir might confer susceptibility. We aimed to find associations between MHC alleles and abacavir hypersensitivity in HIV-1-positive individuals treated with abacavir...
  2. ncbi Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir
    D Nolan
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Australia
    AIDS 15:1275-80. 2001
    ....
  3. ncbi HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay
    E Hammond
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Wellington Street, Western Australia 6000, Australia
    Tissue Antigens 70:58-61. 2007
    ..In conclusion, the AS-PCR/melting curve approach minimises post-polymerase chain reaction handling processing and provides an attractive alternative to currently described AS-PCR methods...
  4. ncbi Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV
    E Hammond
    Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA, Australia
    Clin Endocrinol (Oxf) 76:201-6. 2012
    ....
  5. ncbi Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis
    D Nolan
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia
    Antivir Ther 6:145-60. 2001
    ....
  6. ncbi The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases
    P Price
    Department of Clinical Immunology, Royal Perth Hospital, Western Australia, Australia
    Immunol Rev 167:257-74. 1999
    ..1 AH. Hence these genes may act as a common co-factor in the diverse immunopathological conditions associated with the 8.1 AH...
  7. ncbi Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care
    S Herrmann
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Perth, WA, Australia
    Intern Med J 38:8-15. 2008
    ....
  8. ncbi Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?
    D Nolan
    Centre for Clinical Immunology and Biomedical Statistics, Royal Perth Hospital and Murdoch University, Western Australia, Australia
    QJM 96:825-32. 2003
    ..Endothelial dysfunction is an early phase of atherogenesis that may be assessed non-invasively with ultrasonography in vivo...